Brain Tumor Surgery in Iran
Treatment of medulloblastoma, a malignant brain tumor of the cerebellum with open and minimally invasive surgery
Medulloblastoma is a type of brain tumor.
Brain tumors occur when healthy brain cells change, grow out of control, and form a mass.
The tumor can be cancerous or benign.
A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body.
A benign tumor is a tumor that does not spread.
The brain and spinal cord make up the central nervous system (CNS), which controls all vital functions, such as thinking, speech, and body power. Meduloblastoma has the highest prevalence in children.
What factors affect the success of treatment?
The success of the treatment of pediatric medulloblastoma brain tumor depends largely on the fact that
Has the tumor been completely removed during surgery and whether the tumor has spread to other parts of the brain or spinal cord.
In addition, the surgeon’s expertise and experience will have a significant impact on the success rate of brain tumor surgery and treatment outcome.
Therefore, it is recommended that you choose the best neurosurgeon in Iran to treat the disease before starting treatment.
What is medulloblastoma?
Causes of Medoblastoma brain tumor
- Lee Framney Syndrome
- Mumps basal cell carcinoma syndrome (Gorlin syndrome)
- Torkat syndrome
Symptoms of medulloblastoma cancer
- A headache that usually starts in the morning when you wake up.
- Nausea and vomiting
- Fatigue
- Lethargy
- Imbalance and lack of coordination
- Problems with motor skills, such as writing
- Neck tilt or diplopia
- Personality or behavioral changes
- Convulsions
- Loss of strength of the lower torso
- back ache
- Urinary and fecal incontinence and loss of bowel or bladder control
- Difficult to write
Diagnosis
Magnetic Resonance Imaging (MRI)
Brain Tumor Surgery in Iran
Although medoblastoma is seen on MRI scans, it is only the result of tissue sampling that confirms the diagnosis.
Histological diagnosis
A neuropathologist examines a tissue sample taken from a surgical tumor under a microscope to make sure it is a medulloblastoma.
If the child has a medulloblastoma tumor, a lumbar puncture test or cerebrospinal fluid biopsy is performed shortly after the initial surgery.
Your doctor will perform other tests if necessary.
Treatment of meduloblastoma in Iran
Third ventricular endoscopic ventriculostomy (ETV) or ventricular-peritoneal shunt (VP shunt)
A brain tumor blocks the cerebrospinal fluid, the fluid that surrounds the spinal cord and brain.
In this case, the neurosurgeon performs a procedure to relieve the symptoms of hydrocephalus and the accumulation of fluid that increases the pressure inside the skull.
In third ventricular endoscopic ventriculostomy, the surgeon makes a small hole for fluid to flow around the obstruction and into the spine.
This procedure is recommended for about 90% of children with symptoms of hydrocephalus.
Sometimes another operation called a peritoneal ventricular shunt is performed, in which a tube is used to drain excess fluid into the abdomen.
Brain Tumor Surgery in Iran
Sometimes surgery is needed to treat hydrocephalus (fluid accumulation in the skull) and to remove the tumor.
Research has shown that the more tumors removed, the better the treatment.
Therefore, the surgeon removes the tumor as much as he can and there is no risk of neurological side effects.
Radiotherapy
In radiation therapy of high-emission waves, a special device is used to damage and kill cancer cells and shrink the tumor.
The pediatrician, in collaboration with the pediatric oncologist, determines the optimal dose of radiation to provide effective treatment without severe side effects.
Chemotherapy
- Orally, in the form of tablets to be taken.
- Intramuscular, intramuscular or adipose tissue injection
- Intravenous, direct injection of the drug into the bloodstream, for example through the serum
- Intrathecal, direct injection of the drug with a needle into the spine
The probability of successful treatment Brain Tumor Surgery in Iran depends on the following factors:
- Tumor molecular subtype (specific genetic mutations within the tumor)
- The age of the child at the time of diagnosis
- Tumor location
- Remaining amount of tumor after surgery
- Tumor spreads to other parts of the central nervous system (brain and spinal cord) or to other parts of the body such as bone
الدکتور مهدي زينلی الزادة – استاذ جراحة المخ و قاعدة الجمجمة
Dr. Mehdi Zeinalizadeh – professor in brain surgery and cranial base